| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.074 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.073 | 0.7 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.7 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |